2m 2m 2m 2m 2m 2m 2m
REPLIMUNE GRP (REPL)
NASDAQ
$12.83-$0.10 (-0.74%)
Price as of Sep 11, 2026 7:30 PM EDT- $1.2BMarket Cap
- 125.48%1-Year Change
- BiotechnologyIndustry
REPLIMUNE GRP (REPL)
$12.83-$0.10 (-0.74%)
REPL | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $12.92 | ||
Change | -$0.32 (-2.42%) | ||
Open | $13.33 | ||
High | $13.74 | ||
Low | $12.40 | ||
Previous Close | $13.24 | ||
Volume | 4,085,047 | ||
30-Day Average Volume | 2,738,172 | ||
1-Week Change | -14.10% | ||
1-Month Change | -5.35% | ||
1-Year Change | 125.48% | ||
3-Year Change | -34.71% | ||
5-Year Change | -59.65% | ||
Fundamentals | |||
Shares Outstanding | 94.2M | ||
Total Assets | $252.4M | ||
Market Cap | $1.2B | ||
Enterprise Value | $1.1B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$69.8M | ||
Free Cash Flow | -$75.7M | ||
EBIT | -$67.2M | ||
EBITDA | -$66.2M | ||
Net Working Capital | $162.4M | ||
EPS | -$0.72 | ||
Enterprise Value/EBITDA | -17 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 12 | ||
P/E | -18 | ||
PEG | -3 | ||
Price/Free Cash Flow | -16 | ||
Price/Operating Cash Flow | -16 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 15 : 1 | ||
Last Split Date | 12/01/2010 | ||
Earnings & Revenue